Growth hormone secretagogues raise growth hormone and IGF-1, which has been studied mainly for effects on body composition and sleep in small groups
research shows no additional benefit above 1 mg daily Important: Doses above 1 mg (1,000 mcg) daily showed no additional metabolic benefits in clinical research
Available to buy in the UK from Peptides Lab UK, 5-Amino-1MQ is one of the most extensively characterised selective NNMT inhibitors in current metabolic research, with published pre-clinical evidence spanning adipocyte biology, diet-induced obesity models, NAD+/SAM pathway studies, skeletal muscle function research, and cancer cell biology
Using co-immunoprecipitation (CO-IP), the study confirmed that FOXO4-DRI prevents FOXO4 binding to p53, facilitating phosphorylated p53 nuclear exclusion, which triggers BAX upregulation and cleaved caspase-3 activation driving selective apoptosis of senescent endothelial cells